Conformational Diseases Group is interested in studying bacterial inclusion bodies as a model to treat amyloid aggregation based human disorders, such as Alzheimer or Parkinson’s diseases.
Raimon Sabaté Lagunas (Associate Professor) rsabate(at)ub.edu
Alba Espargaró Colomé (Tenure-Track Lecturer)
On the Binding of Congo Red to Amyloid Fibrils. Espargaró A., Llabrés S., Saupe S.J., Curutchet C., Luque F.J., Sabaté R. Angewandte Chemie – International Edition. 2020, 59(21)
1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer’s disease. Wichur T., Więckowska A., Więckowski K., Godyń J., Jończyk J., Valdivieso ÁD.R., Panek D., Pasieka A., Sabaté R., Knez D., Gobec S., Malawska B. European journal of medicinal chemistry. 2020, 187
“Nanocarriers for drug delivery through thermal release”. CTQ2017-88446-R. IP2: Sabaté, Raimon. Ministerio de Economía y Competitividad of Spain. 2018 –2020.